Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Drug Costs The confluence of significant list price increases, the growth of HDHPs and lightning-bolt stories such as the 500 percent price increase forEpiPen put a tremendous amount of pressure on the rebating system. (Photo: Shutterstock)

Clients often ask about the future of drug rebates. How do they keep growing? Are they sustainable?


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.